Compared with an injection of saline placebo, a single intra-articular injection of autologous adipose-derived mesenchymal stromal cells showed no significant improvement in pain or function scores in ...

In a world-first breakthrough, scientists have discovered how a sugary “cloak” helps bowel cancer hide from the immune system ...

This patient guide explains gastrointestinal stromal tumors, covering diagnosis, treatment options, targeted therapies and practical care tips.

The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...

University of Galway have made a breakthrough in understanding the body’s response to bowel cancer, opening up new treatment possibilities for people.

Imaging data from the phase 2 MINDFuL trial in Alzheimer’s Disease should be released in Q4 2025. Final data on the INKmune CARE-PC trial is expected in Q4 2025. Financial Results for the Third ...

Stempeutics Research, backed by Manipal Group, has inked a licensing deal with Medinet to introduce its stem cell therapy ...

Mesoblast Limited (NASDAQ:MESO), together with its subsidiaries, develops regenerative medicine products in Australia, the US ...